Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: five-year results from the phase III KEYNOTE-564 study ☆

Annals of Vascular Surgery · Elsevier

Аннотация

Publication date: November 2026 Source: Annals of Oncology, Volume 37, Issue 11 Author(s): N.B. Haas, T.B. Powles, P. Tomczak, S.H. Park, B. Venugopal, S.N. Symeonides, T. Ferguson, Y.-H. Chang, J.-L. Lee, P. Sawrycki, N. Sarwar, H. Gurney, M. Gross-Goupil, J.M. Burke, G. Doshi, J. Cornell, J.E. Burgents, R.F. Perini, T.K. Choueiri

Читать у издателя →

Похожие статьи